Biotech News
Related news
LUNGPulmonx2026-10-13 20:05 EST
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
LUNGPulmonx2026-10-27 20:05 EST
Pulmonx Reports Third Quarter 2026 Financial Results
ICCMIceCure Medical2026-11-11 13:30 EST
IceCure Medical to Report Third Quarter 2026 Financial and Operating Results on November 18, 2026
SGHTSight Sciences2026-11-04 21:05 EST
Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance
ACHCAcadia Healthcare2026-11-04 21:05 EST
Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance
CVRXCVRx2026-10-22 20:30 EST
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
DNLIDenali Therapeutics2026-10-22 20:01 EST
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
STIMNeuronetics2026-10-21 12:30 EST
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
PULMPulmatrix2026-11-17 13:05 EST
Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger
PAVMPAVmed2026-11-12 13:00 EST
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results
Pulmonx
Minimally Invasive COPD Treatment Pulmonx develops minimally invasive technologies for patients with severe emphysema and chronic obstructive pulmonary disease who remain highly symptomatic despite medical therapy. Zephyr Endobronchial Valve The Zephyr Valve is an implantable bronchoscopic device that occludes selected diseased lung...
Recent company news
LUNGPulmonx2026-11-18 21:05 EST
Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference
LUNGPulmonx2026-11-17 12:10 EST
Pulmonx Announces Publication of CONVERT Trial Results for AeriSeal® System
LUNGPulmonx2026-10-28 20:05 EST
Pulmonx to Participate in Upcoming Investor Conferences
LUNGPulmonx2026-10-27 20:05 EST
Pulmonx Reports Third Quarter 2026 Financial Results
LUNGPulmonx2026-10-13 20:05 EST
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
Stock data
- Close
- 2.74 USD
- Market cap
- 68M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States
